France's Cytoo Raises $4.7M to Grow High-Content Cell Analysis Business | GenomeWeb

NEW YORK (GenomeWeb News) – French high-content screening shop Cytoo said today that it has raised $4.7 million in a second funding round.

Cytoo, based in Grenoble, said that it will use the proceeds to grow its business internationally, and to expand its team and R&D efforts around its high-content cell-based screening tools for the life science research market.

New investor Auriga Partners led the financing, while existing investor Jacques Lewiner, the company's co-founder and supervisory board president, also participated.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.